Headquartered in Wilmington, DE·Fiscal year ends September·NYSE: ASH·ashland.com
About Ashland
Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with approximately 2,800 employees serving customers in more than 100 countries. It operates four reportable segments.
- **Life Sciences** supplies pharmaceutical excipients and technologies, including VP&D, cellulosics, injectables and film/tablet coatings, along with nutrition ingredients.
- **Personal Care** offers biofunctional actives, microbial protection and care ingredients for hair, skin, oral care and household applications.
- **Specialty Additives** provides rheology modifiers such as HEC for architectural coatings, plus construction, energy and resources, and performance specialties applications.
- **Intermediates** produces BDO and NMP for merchant and captive use, including emerging energy-storage customers.
The company is pursuing an 'Execute, Globalize and Innovate' strategy focused on plant productivity, notably at its Hopewell HEC facility. The strategy also aims to expand geographically and commercialize new technologies. Ashland has recently divested its Avoca and Nutraceutical businesses and liquidated its Argentine entity. Updated
A 31% drop in Specialty Additives adjusted EBITDA, blamed on weak Energy and Resources demand and poor productivity at the Hopewell plant, pushed adjusted EPS below consensus and left GAAP results at a loss from continuing operations of $17 million. Management says the Hopewell drag is finished now that capital work is complete, and guided fiscal 2027 adjusted EBITDA to $405 million to $435 million. That guidance is the number to judge the turnaround on.
Most investors chase the same megacap names. But sometimes the most interesting setups are hiding in plain sight: a micro-cap media company quietly becoming a digital business, a uniform rental operator working…
Pre-Market Stock Futures: Futures are trading higher on Monday as we head into the final trading weeks of 2025. All of the major indices were hit hard on Friday as investors began…
Thursday's top analyst upgrades and downgrades included Brixmor Property, CAVA, Chevron, GE Healthcare Technologies, Keurig Dr Pepper, News Corp, PACCAR, Permian Resources, Pioneer Natural Resources, Sea and Visa.
Tuesday's top analyst upgrades and downgrades included Advance Auto Parts, Alphabet, Biogen, Cheesecake Factory, Chesapeake Energy, Micron Technology, MongoDB, Ross Stores, Tesla and TG Therapeutics.
Friday's top analyst upgrades and downgrades included FedEx, First Solar, Fortinet, Hasbro, Meta Platforms, Okta, Peloton Interactive, Qualtrics International, United Parcel Service and Waste Management.
Tuesday's top analyst upgrades and downgrades included Adobe, Agnico Eagle Mines, Amgen, Barrick Gold, Comstock Resources, Enphase Energy, Huntsman, JD.com, Kinder Morgan, Lucid, Newmont, Okta, Starbucks, Union Pacific and Vale.
Lowe’s and Medtronic are among the top companies expected to lift the dividends they pay to shareholders this week, making their stocks good total return candidates.
Friday's top analyst upgrades and downgrades included Beyond Meat, Carvana, Embraer, Lennar, Moderna, Paysafe, Peloton Interactive, PulteGroup, Ventas, VICI Properties and Vroom.
Credit Suisse has made seven additions to its list of top picks. They are listed as having the "highest conviction combined with the least demanding market expectations."
The top analyst upgrades, downgrades and initiations on Friday included Apple, Broadcom, Charter Communications, Comcast, CommScope, Consolidated Edison, Next Era Energy, Rockwell Automation and Transocean.
The top analyst upgrades, downgrades and other research calls from Thursday included Altbaba, AutoDesk, AutoZone, CBS, Eli Lilly, Lululemon, Michael's and Target.
Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with approximately 2,800 employees serving customers in more than 100 countries.
What is the ASH stock price target?
24/7 Wall St.'s 12-month price target for ASH is $81.87, rated Buy. The Wall Street consensus target is $82.45. ASH price prediction →
